Answers are grounded in this paper and cite their sources.
Treatment of N - tert -butyl-4-( tert -butylimino)-2-penten-2-amine with [CpMgMe(Et 2 O)] 2 in diethyl ether afforded CpMg(HC(C(Me)N(tBu)) 2 ) (90%). A crystal structure determination of this complex revealed a sandwich structure with a π-coordinated β-diketiminato ligand. CpMg(HC(C(Me)N(tBu)) 2 ) did not form isolable adducts with diethyl ether or tetrahydrofuran, but treatment with 4- tert -butylpyridine led to the formation of CpMg(HC(C(Me)N(tBu)) 2 )(4-tBupy) (88%). A crystal structure determination showed that CpMg(HC(C(Me)N(tBu)) 2 )(4-tBupy) possesses a η 2 -β-diketiminato ligand with some distortion toward π-bonding, but not as much as was found in CpMg(HC(C(Me)N(tBu)) 2 ). Similar treatment of N -isopropyl-4-(isopropylimino)-2-penten-2-amine with [CpMgMe(Et 2 O)] 2 and 4- tert -butylpyridine in diethyl ether afforded CpMg(HC(C(Me)N(iPr)) 2 )(tBupy) (73%). The crystal structure of this complex was very similar to that of CpMg(HC(C(Me)N(tBu)) 2 )(4-tBupy). In the absence of 4- tert -butylpyridine, CpMg(HC(C(Me)N(iPr)) 2 )(OEt 2 ) was isolated, but this complex decomposed slowly to mixtures of Cp 2 Mg and Mg(HC(C(Me)N(iPr)) 2 ) 2 upon loss of the labile diethyl ether ligand. Treatment of dibutylmagnesium with 2 equiv of N - tert -butyl-4-( tert -butylimino)-2-penten-2-amine or N -isopropyl-4-(isopropylimino)-2-penten-2-amine in hexane afforded Mg(HC(C(Me)N(tBu)) 2 ) 2 (68%) or Mg(HC(C(Me)N(iPr)) 2 ) 2 (78%). Crystal structure determinations of Mg(HC(C(Me)N(tBu)) 2 ) 2 and Mg(HC(C(Me)N(iPr)) 2 ) 2 revealed η 2 -β-diketiminato ligands and approximate tetrahedral geometry about the magnesium ions. The thermal stability and volatility of the complexes were determined through preparative sublimation experiments.
No takes yet. Share an insight, caveat, or question.
El‐Kaderi et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: